Abstract
The value of morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression for prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients was evaluated in a group of CMF treated patients and controls with long-term follow-up. In the treated group, the Morphometric Prognostic Index (cutpoint 1.1) was the best prognosticator (p
Original language | English (US) |
---|---|
Pages (from-to) | 344-349 |
Number of pages | 6 |
Journal | Pathology Research and Practice |
Volume | 188 |
Issue number | 3 |
State | Published - 1992 |
Externally published | Yes |
ASJC Scopus subject areas
- Pathology and Forensic Medicine